2-acetylaminofluorene has been researched along with Body Weight in 60 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Two diets used widely in toxicological and/or nutritional studies, and considered to be nutritionally adequate, were compared with respect to their influence on growth, body weight, lifespan, spontaneous neoplasia, and neoplastic responses to 2-acetylaminofluorene (2-AAF)." | 3.68 | Effects of diet type on incidence of spontaneous and 2-acetylaminofluorene-induced liver and bladder tumors in BALB/c mice fed AIN-76A diet versus NIH-07 diet. ( Bucci, TJ; Fullerton, FR; Greenman, DL, 1992) |
| " Rats were initially given a single ip injection of diethylnitrosamine (200 mg/kg body weight) and fed basal diet containing 0." | 3.67 | Inhibitory effects of ethoxyquin, 4,4'-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis. ( Inoue, K; Ito, N; Masui, T; Ogiso, T; Tsuda, H, 1986) |
| " In contrast, the liver neoplasm promoter phenobarbital increased the multiplicity, although not the incidence, of liver neoplasms when given after FAA." | 3.67 | Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide. ( Furuya, K; Levine, WG; Mori, H; Numoto, S; Williams, GM, 1985) |
| "The relationships between the shelf level at which mice were housed and body weight and food consumption/wastage were examined by analyzing data obtained from the first 9 months of a carcinogenic dose-response study carried out in 24,192 female BALB/c mice using 2-acetylaminofluorene (2-AAF) as the carcinogen." | 3.66 | Relationship of mouse body weight and food consumption/wastage to cage shelf level. ( Bryant, P; Greenman, DL; Kodell, RL; Sheldon, W, 1983) |
| "Acetaminophen was given in the diet either alone at 2400 or 4800 p." | 1.34 | Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene. ( Duan, JD; Iatropoulos, MJ; Jeffrey, AM; Perrone, CE; Williams, GM, 2007) |
| "5 ppm dosage in drinking water in a defined model of a two-stage experimental rat hepatocarcinogenesis." | 1.33 | Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. ( Chakraborty, T; Chatterjee, A; Chatterjee, M; Dhachinamoorthi, D; Saralaya, MG, 2006) |
| " From 5 weeks after the completion of 2-AAF administration, the rats were orally dosed with 0." | 1.32 | Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation. ( Akahane, M; Hayashi, M; Kuroda, J; Machida, N; Mitsumori, K; Moriwaki, H; Ohnota, H; Shibata, N; Tamura, T, 2004) |
| " At nodular and post-nodular stages biliary excretion of radioactive metabolites was decreased, although hepatic content of radioactivity was similar to controls not dosed with AAF." | 1.28 | Protein binding, nuclear translocation and biliary secretion of metabolites of 3'-methyl-N,N-dimethyl-4-aminoazobenzene during hepatocarcinogenesis in rats. ( Bhargava, MM; Levine, WG; Srinivasan, K, 1991) |
| " Each group consisted of 96 mice, except the groups of females dosed at 0 and 150 ppm, which consisted of 120 and 72 mice, respectively." | 1.28 | Increased incidence of spontaneous and 2-acetylaminofluorene-induced liver and bladder tumors in B6C3F1 mice fed AIN-76A diet versus NIH-07 diet. ( Bucci, TJ; Fullerton, FR; Greenman, DL; McCarty, CC, 1991) |
| " However, sodium saccharin dosing did not result in an increased incidence of tumors in either the bladder or liver and is therefore not considered to be a promoter of carcinogenesis at these sites in the mouse." | 1.28 | The effect of lifetime sodium saccharin dosing on mice initiated with the carcinogen 2-acetylaminofluorene. ( Dooley, KL; Frederick, CB; Kadlubar, FF; Kodell, RL; Sheldon, WG, 1989) |
| "(c) Spermine levels were significantly lowered, with 3 minima corresponding to the putrescine maxima." | 1.26 | Intrahepatic polyamine levels during rat liver carcinogenesis induced by N-2-fluorenylacetamide. ( Aussel, C; Lafaurie, M; Lalanne, CM; Milano, G; Soula, G; Stora, C, 1981) |
| "Lower body weight was observed in operated rats but it is not considered to be the major cause of a complete inhibition of mammary tumor induction." | 1.26 | An inhibitory effect of salivary gland extirpation on the induction of mammary tumors in rats by N,N'-2,7-fluorenylenebisacetamide. ( Hirano, T; Jackson, CM; Lewis, JW; Morris, HP, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (55.00) | 18.7374 |
| 1990's | 18 (30.00) | 18.2507 |
| 2000's | 9 (15.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furtado, KS | 1 |
| Pires, PW | 1 |
| Justulin, LA | 1 |
| Rodrigues, MA | 1 |
| Felisbino, SL | 1 |
| Barbisan, LF | 2 |
| Cui, R | 1 |
| Wang, B | 1 |
| Zhang, F | 1 |
| Chen, G | 1 |
| Yin, S | 1 |
| Espandiari, P | 1 |
| Glauert, HP | 1 |
| Lehmler, HJ | 1 |
| Lee, EY | 1 |
| Srinivasan, C | 1 |
| Robertson, LW | 1 |
| Hayashi, M | 2 |
| Ohnota, H | 2 |
| Tamura, T | 2 |
| Kuroda, J | 2 |
| Shibata, N | 2 |
| Akahane, M | 2 |
| Moriwaki, H | 1 |
| Machida, N | 1 |
| Mitsumori, K | 2 |
| Kashida, Y | 1 |
| Chakraborty, T | 2 |
| Samanta, S | 1 |
| Ghosh, B | 1 |
| Thirumoorthy, N | 1 |
| Chatterjee, M | 2 |
| Chatterjee, A | 1 |
| Saralaya, MG | 1 |
| Dhachinamoorthi, D | 1 |
| Williams, GM | 7 |
| Iatropoulos, MJ | 1 |
| Jeffrey, AM | 1 |
| Duan, JD | 1 |
| Perrone, CE | 1 |
| Laishes, BA | 2 |
| Rolfe, PB | 1 |
| Numoto, S | 2 |
| Furukawa, K | 1 |
| Furuya, K | 2 |
| Hosaka, S | 1 |
| Nagayama, H | 1 |
| Hirono, I | 1 |
| Greenman, DL | 4 |
| Bryant, P | 1 |
| Kodell, RL | 2 |
| Sheldon, W | 1 |
| Malejka-Giganti, D | 1 |
| McIver, RC | 1 |
| Rydell, RE | 1 |
| Depass, LR | 1 |
| Morris, MD | 1 |
| Milano, G | 1 |
| Aussel, C | 2 |
| Stora, C | 3 |
| Lafaurie, M | 3 |
| Soula, G | 1 |
| Lalanne, CM | 1 |
| Mori, H | 7 |
| Tanaka, T | 8 |
| Nishikawa, A | 1 |
| Takahashi, M | 2 |
| Peraino, C | 2 |
| Krebs, B | 2 |
| Staffeldt, EF | 1 |
| Haugen, DA | 1 |
| Lombard, LS | 1 |
| Stevens, FJ | 1 |
| Fry, RJ | 1 |
| Lok, E | 1 |
| Mehta, R | 1 |
| Jee, P | 1 |
| Laver, G | 1 |
| Nera, EA | 1 |
| McMullen, E | 1 |
| Clayson, DB | 1 |
| La Porta, CA | 1 |
| Comolli, R | 1 |
| Storer, RD | 1 |
| Cartwright, ME | 1 |
| Cook, WO | 1 |
| Soper, KA | 1 |
| Nichols, WW | 1 |
| Ho, YS | 1 |
| Lin, JK | 1 |
| Blanck, A | 1 |
| Assefaw-Redda, Y | 1 |
| Eriksson, LC | 1 |
| Gustafsson, JA | 1 |
| Ekvärn, S | 1 |
| Hällström, IP | 1 |
| Tokumo, K | 1 |
| Umemura, T | 1 |
| Sirma, H | 1 |
| Gebhardt, R | 1 |
| Poirier, MC | 1 |
| Kojima, T | 1 |
| Okumura, A | 1 |
| Sugie, S | 2 |
| Hagiwara, A | 1 |
| Tanaka, H | 1 |
| Imaida, K | 2 |
| Tamano, S | 1 |
| Fukushima, S | 1 |
| Ito, N | 4 |
| Pascale, RM | 1 |
| Simile, MM | 1 |
| DeMiglio, MR | 1 |
| Muroni, MR | 1 |
| Gaspa, L | 1 |
| Dragani, TA | 1 |
| Feo, F | 1 |
| Danz, M | 1 |
| Sänger, J | 1 |
| Friedrichsen, K | 1 |
| Linss, W | 1 |
| Shimizu, I | 1 |
| Yasuda, M | 1 |
| Mizobuchi, Y | 1 |
| Ma, YR | 1 |
| Liu, F | 1 |
| Shiba, M | 1 |
| Horie, T | 1 |
| Ito, S | 1 |
| Spinardi-Barbisan, AL | 1 |
| Kaneno, R | 1 |
| Marchesan Rodrigues, MA | 1 |
| Fávero Salvadori, DM | 1 |
| Trindade Moreira, EL | 1 |
| Viana de Camargo, JL | 1 |
| Bushnell, DE | 1 |
| Jeter, JR | 1 |
| Yamamoto, RS | 1 |
| Weisburger, EK | 2 |
| Mohan, LC | 1 |
| Grantham, PH | 1 |
| Weisburger, JH | 2 |
| Idoine, JB | 1 |
| Hirano, T | 1 |
| Morris, HP | 1 |
| Jackson, CM | 1 |
| Lewis, JW | 1 |
| Littlefield, NA | 1 |
| Cueto, C | 1 |
| Davis, AK | 1 |
| Medlock, K | 1 |
| Goodman, JI | 1 |
| Trosko, JE | 1 |
| Yager, JD | 1 |
| Reuber, MD | 1 |
| Fullerton, FR | 2 |
| Bucci, TJ | 2 |
| Ogawa, K | 1 |
| Hasegawa, R | 2 |
| Wada, S | 1 |
| Yamaguchi, S | 2 |
| Srinivasan, K | 1 |
| Levine, WG | 2 |
| Bhargava, MM | 1 |
| Takahashi, S | 1 |
| Shirai, T | 1 |
| Maruyama, H | 2 |
| Maeura, Y | 1 |
| Zang, E | 1 |
| Takeuchi, T | 1 |
| Shimizu, M | 1 |
| Morishita, Y | 1 |
| Mori, Y | 3 |
| McCarty, CC | 1 |
| Castelli, D | 1 |
| Seralini, GE | 1 |
| Frederick, CB | 1 |
| Dooley, KL | 1 |
| Sheldon, WG | 1 |
| Kadlubar, FF | 1 |
| Niwa, K | 2 |
| Yoshimi, N | 1 |
| Iwata, H | 2 |
| Hara, A | 1 |
| LeBoeuf, RA | 1 |
| Hoekstra, WG | 1 |
| Masui, T | 1 |
| Tsuda, H | 1 |
| Inoue, K | 1 |
| Ogiso, T | 1 |
| Shima, H | 1 |
| Kuniyasu, T | 1 |
| Muto, Y | 1 |
| Rajpurohit, R | 1 |
| Krishnaswamy, K | 1 |
| Randerath, K | 1 |
| Lu, LJ | 1 |
| Li, D | 1 |
| Shimizu, A | 1 |
| Hiramatsu, N | 1 |
| Kishida, T | 1 |
| Natake, M | 1 |
| Boothe, A | 1 |
| Kodell, R | 1 |
| Daoud, AH | 1 |
| Griffin, AC | 1 |
1 review available for 2-acetylaminofluorene and Body Weight
| Article | Year |
|---|---|
The role of hormones on digestive and urinary tract carcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Carcinogens; Diet; Female; Food; Gonadal Steroid Hormon | 1976 |
59 other studies available for 2-acetylaminofluorene and Body Weight
| Article | Year |
|---|---|
Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Diethylnitrosamine; Disease Progression; Glutathione S- | 2009 |
Suppressive effect of herbal compound 861 on chemical hepatocarcinogenesis in rats.
Topics: 2-Acetylaminofluorene; Animals; Blotting, Northern; Blotting, Western; Body Weight; Diethylnitrosami | 2003 |
Initiating activity of 4-chlorobiphenyl metabolites in the resistant hepatocyte model.
Topics: 2-Acetylaminofluorene; Adenoma, Liver Cell; Administration, Oral; Animals; Biphenyl Compounds; Body | 2004 |
Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Topics: 2-Acetylaminofluorene; Animals; Apoptosis; Body Weight; Carcinogens; Cell Proliferation; Diethylnitr | 2004 |
Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Topics: 2-Acetylaminofluorene; Animals; Anticarcinogenic Agents; Apoptosis; Body Weight; Carcinogens; Cell P | 2005 |
Vanadium induces apoptosis and modulates the expressions of metallothionein, Ki-67 nuclear antigen, and p53 during 2-acetylaminofluorene-induced rat liver preneoplasia.
Topics: 2-Acetylaminofluorene; Animals; Apoptosis; Body Weight; DNA Damage; Gene Expression Regulation; Ki-6 | 2005 |
Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
Topics: 2-Acetylaminofluorene; Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Chromosome Aberra | 2006 |
Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
Topics: 2-Acetylaminofluorene; Acetaminophen; Animals; Antineoplastic Agents; Body Weight; Carcinoma, Hepato | 2007 |
Search for endogenous liver colony-forming units in F344 rats given a two-thirds hepatectomy during short-term feeding of 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Clone Cells; Diet; DNA, Neoplasm; gamma-Glutamyltransfe | 1981 |
Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Alkaline Phosphatase; Animals; Body Weight; Cell Division; Cell Membrane; Clo | 1984 |
Suppressive effect of caffeine on the development of hepatic tumors induced by 2-acetylaminofluorene in ACI rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Caffeine; Drinking; Eating; Enzyme Induction; Liver Neo | 1984 |
Relationship of mouse body weight and food consumption/wastage to cage shelf level.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Feeding Behavior; Female; Housing, Animal; Mice; Mice, | 1983 |
Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Adenocarcinoma; Adenofibroma; Adenoma; Animals; Biotransformation; Body Weigh | 1980 |
Feedback control of cholesterol biosynthesis in rats fed the liver carcinogens benzidine and 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Benzidines; Body Weight; Cholesterol; Feedback; Liver; Male; Rats; S | 1981 |
Intrahepatic polyamine levels during rat liver carcinogenesis induced by N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Female; Liver Neoplasms; Neoplasms, Experimental; Organ | 1981 |
Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
Topics: 2-Acetylaminofluorene; Animals; Barbital; Barbiturates; Body Weight; Kinetics; Liver; Male; Organ Si | 1981 |
Initiation and promotion of liver tumorigenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Carcinogens; Kinetics; Liver Neoplasms; Neoplasms, Expe | 1981 |
Modifications in adrenal activity during hepatocarcinogenesis by N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Adrenal Glands; Aldosterone; Animals; Body Weight; Estradiol; Female; Liver N | 1980 |
Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Drug Synergism; | 1980 |
The effect of butylated hydroxytoluene on the growth of enzyme-altered foci in male Fischer 344 rat liver tissue.
Topics: 2-Acetylaminofluorene; Analysis of Variance; Animals; Antioxidants; Body Weight; Butylated Hydroxyto | 1995 |
Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Carcinogens; Caseins; Diet; Diethylnitrosamine; gamma-G | 1995 |
Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice.
Topics: 2-Acetylaminofluorene; Animals; Benzene; Biotransformation; Body Weight; Carcinogenicity Tests; Carc | 1995 |
N-nitroso-2-acetylaminofluorene: a direct-acting carcinogen inducing hepatocellular carcinoma in Sprague-Dawley rats.
Topics: 2-Acetylaminofluorene; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Body | 1994 |
Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Androstenedione; Animals; Body Weight; Cell Division; Diethylnitrosamine; Fem | 1994 |
Inhibition by gonadectomy of effects of 2-acetylaminofluorene in livers of male, but not female rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; DNA; Dose-Response Relationship, Drug; Female; Liver; M | 1993 |
Inhibitory effect of the non-steroidal anti-inflammatory drugs, indomethacin and piroxicam on 2-acetylaminofluorene-induced hepatocarcinogenesis in male ACI/N rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Indomethacin; Liver; Liver Neoplasms, Experimental; Mal | 1993 |
Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Butylated Hydroxyanisole; Carcinogenicity Tests; Carcin | 1993 |
The BN rat strain carries dominant hepatocarcinogen resistance loci.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Carcinogens; Genes, Dominant; Genetic Predisposition to | 1996 |
2-Acetylaminofluorene-produced selective cytotoxic damage of a ductal compartment and its repair in the submandibular gland of rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Cell Survival; Male; Mutagens; Organ Size; Rats; Rats, | 1997 |
Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats.
Topics: 2-Acetylaminofluorene; Animals; Biomarkers, Tumor; Body Weight; Diethylnitrosamine; Estradiol; Femal | 1998 |
Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats.
Topics: 1,2-Dimethylhydrazine; 2-Acetylaminofluorene; Alkylating Agents; Animals; Body Weight; Butylhydroxyb | 2000 |
Effects of 2-acetylaminofluorene on diurnal oscillations in nucleic acid metabolism in two classes of nuclei isolated from rat liver.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Cell Nucleus; Circadian Rhythm; DNA; Fasting; Fluorenes | 1978 |
Mechanisms of the inhibitory action of p-hydroxyacetanilide on carcinogenesis by N-2-fluorenylacetamide or N-hydroxy-N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Acetaminophen; Amidohydrolases; Animals; Body Weight; Eating; Feces; Fluorene | 1976 |
An inhibitory effect of salivary gland extirpation on the induction of mammary tumors in rats by N,N'-2,7-fluorenylenebisacetamide.
Topics: 2-Acetylaminofluorene; Adenocarcinoma; Animals; Atrophy; Body Weight; Diet; Female; Fluorenes; Mamma | 1976 |
Chronic dose-response studies in mice fed 2-AAF.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Female; Fluoren | 1975 |
Studies on the mechanism of inhibition of 2-acetylaminofluorene toxicity by butylated hydroxytoluene.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Butylated Hydroxytoluene; Cell Nucleus; Cresols; DNA; D | 1976 |
Effect of age and testosterone on the induction of hyperplastic nodules, carcinomas, and cirrhosis of the liver in rats ingesting n-2-fluorenyldiacetamide.
Topics: 2-Acetylaminofluorene; Age Factors; Animals; Body Weight; Castration; Fluorenes; Hyperplasia; Liver | 1976 |
Effects of diet type on incidence of spontaneous and 2-acetylaminofluorene-induced liver and bladder tumors in BALB/c mice fed AIN-76A diet versus NIH-07 diet.
Topics: 2-Acetylaminofluorene; Adenoma; Animals; Body Weight; Carcinoma, Hepatocellular; Eating; Female; Foo | 1992 |
Dose response study of N-nitrosodiethanolamine initiation of rat hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Chemical and Drug Induced Liver Injury; Cocarcinogenesi | 1991 |
Protein binding, nuclear translocation and biliary secretion of metabolites of 3'-methyl-N,N-dimethyl-4-aminoazobenzene during hepatocarcinogenesis in rats.
Topics: 2-Acetylaminofluorene; Animals; Bile; Body Weight; Carcinogens; Cell Nucleus; Chromatography, Gel; C | 1991 |
Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
Topics: 2-Acetylaminofluorene; Acetaminophen; Aging; Animals; Biomarkers, Tumor; Body Weight; Carcinogens; D | 1991 |
Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Butylated Hydroxytoluene; Dose-Response Relationship, D | 1991 |
Modifying effects of anticancer drugs adriamycin, actinomycin D, and cisplatin on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
Topics: 2-Acetylaminofluorene; Administration, Oral; Animals; Body Weight; Cisplatin; Dactinomycin; Doxorubi | 1991 |
Increased incidence of spontaneous and 2-acetylaminofluorene-induced liver and bladder tumors in B6C3F1 mice fed AIN-76A diet versus NIH-07 diet.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Diet; Eating; Energy Intake; Female; Growth; Liver Neop | 1991 |
Ovarian function during aflatoxin B1-induced hepatocarcinogenesis in the rat.
Topics: 2-Acetylaminofluorene; Aflatoxin B1; Aflatoxins; alpha-Fetoproteins; Animals; Body Weight; Dietary P | 1986 |
The effect of lifetime sodium saccharin dosing on mice initiated with the carcinogen 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Diet; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H | 1989 |
Induction of altered hepatocellular foci of hamster for a possible short-term assay for carcinogens.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Carbon Tetrachloride; Carcinogens; Cricetinae; Liver; M | 1989 |
Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Diet; Diethylnitrosamine; Dose-Response Relationship, D | 1985 |
Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
Topics: 2-Acetylaminofluorene; Animals; Benzopyrans; Body Weight; Ellagic Acid; gamma-Glutamyltransferase; L | 1988 |
Inhibitory effects of ethoxyquin, 4,4'-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Acetaminophen; Aniline Compounds; Animals; Body Weight; Butylated Hydroxyanis | 1986 |
Inhibitory effects of polyprenoic acid (E-5166) on N-2-fluorenylacetamide-initiated hepatocarcinogenesis in rats.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Drug Antagonism; Liver; Liver Neoplasms, Experimental; | 1986 |
Differences in response of glucuronide and glutathione conjugating enzymes to aflatoxin B1 and N-acetylaminofluorene in underfed rats.
Topics: 2-Acetylaminofluorene; Administration, Oral; Aflatoxin B1; Aflatoxins; Animals; Aryl Hydrocarbon Hyd | 1988 |
A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver.
Topics: 2-Acetylaminofluorene; 5-Methylcytosine; Adenosine Triphosphate; Animals; Body Weight; Cytosine; DNA | 1988 |
Experimental studies on hepatic cirrhosis and hepatocarcinogenesis. II. Influence of cirrhotic liver on 2-FAA hepatocarcinogenesis in rats.
Topics: 2-Acetylaminofluorene; Administration, Oral; Animals; Body Weight; Furaldehyde; Histocytochemistry; | 1986 |
Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Cell Division; Cocarcinogenesis; Diethylhexyl Phthalate | 1987 |
Effect of autoxidized linoleic acid on the contents of cytochrome P-450 and cytochrome b5, and drug-metabolizing enzyme activities in rat liver.
Topics: 2-Acetylaminofluorene; Aminopyrine N-Demethylase; Animals; Body Weight; Cytochrome b Group; Cytochro | 1987 |
Age-dependent responses to 2-acetylaminofluorene in BALB/c female mice.
Topics: 2-Acetylaminofluorene; Aging; Animals; Body Weight; Environment; Female; Liver Neoplasms; Liver Neop | 1987 |
Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Administration, Oral; Animals; Body Weight; Carcinogens; Drug Synergism; Live | 1985 |
Effect of retinoic acid, butylated hydroxytoluene, propylgallate and selenium on 2-acetylaminofluorene induced hepatotoxicity.
Topics: 2-Acetylaminofluorene; Animals; Body Weight; Butylated Hydroxytoluene; Drug Interactions; Female; Ga | 1985 |